Insider / KIMBERLY CLARK CORP
Romanelli Joseph
Director at KIMBERLY CLARK CORP
- Company
- KIMBERLY CLARK CORP
- First filing on record
- January 5, 2026
- Latest trade on record
- January 26, 2026
- SEC filings
- EDGAR ↗
Romanelli Joseph, Director at KIMBERLY CLARK CORP, has disclosed 2 transactions in MRK, KMB since January 5, 2026: 0 purchases (0 open-market buys) and 0 sales, worth about $613K at the reported prices. The latest was filed January 28, 2026, 2 days after the trade.
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
In the last 12 months Romanelli Joseph reported 2 transactions that were neither a purchase nor a sale, such as stock awards, option exercises or shares withheld for tax.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
0 of 2 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| A | Grant or award | 2 | 7,626 | $613K |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 2 | 0 | 0 |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| MRK | Other A | January 26, 2026 | January 28, 2026 | 2d | 5,703 | $107 | $613K | Form 4 ↗ | ||
| KMB | Other A | January 2, 2026 | January 5, 2026 | 3d | 1,923 | — | — | derivative | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| January 28, 2026 | Form 4 | 0000310158-26-000022 | 1 | published | EDGAR ↗ |
| January 5, 2026 | Form 4 | 0001225208-26-000221 | 1 | published | EDGAR ↗ |
Other insiders at KIMBERLY CLARK CORP
- Karsanbhai Surendralal Lanca Director 30 rows
- Fenske Tamera Chief Supply Chain Officer 20 rows
- Zachary Jennifer EVP, General Counsel 20 rows
- Warden Kathy J Chair, CEO and President 19 rows
- Williams David Michael EVP,Chief Info&Digital Officer 19 rows
- Hsu Michael D. Director 17 rows
- RUSSO PATRICIA F Director 16 rows
- Smart Dalton E. III SVP Fin. - Global Controller 16 rows
- DeLuca Richard R. EVP&Pres, Merck Animal Heallth 15 rows
- Melucci Jeffrey P. Chief Bus., Strat. & Admin. 15 rows
Everyone on file, with contracts and lobbying under the company's name: KIMBERLY CLARK CORP.
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 2 | 2 | January 5, 2026 | January 28, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.